article thumbnail

AstraZeneca's Enhertu and Akeso's bispecifics win national coverage in China as CAR-T therapies miss out again

Fierce Pharma

AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med being a part of an ongoing investigation in the count | AstraZeneca’s Daiichi Sankyo-partnered antibody-drug conjugate Enhertu has made it onto China’s national insurance program despite the star med being (..)

Insurance 253
article thumbnail

American Hospital Association turns up the heat on commercial insurers in scathing report

MedCity News

Commercial insurers’ practices, such as prior authorization and white bagging, are needed to reduce costs for patients, said Kristine Grow, senior vice president of communications at AHIP.

Insurance 315
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck entitled to $1.4B in cyberattack case after court rejects insurers' 'warlike action' claim

Fierce Pharma

in cyberattack case after court rejects insurers' 'warlike action' claim aliu Tue, 05/02/2023 - 10:07 Merck entitled to $1.4B

Insurance 310
article thumbnail

AHIP Targets Big Pharma in New Campaign

MedCity News

America’s Health Insurance Plans’ new campaign aims to show how health insurers are working to create savings for Americans while also targeting Big Pharma (or more specifically drug manufacturers) for increasing drug costs. The ads will be distributed on TV, social media and streaming services.

Pharma 271
article thumbnail

Merck settles with insurance companies over $1.4B claim tied to 2017 cyberattack: report

Fierce Pharma

Merck has reportedly settled with insurance companies that contested the pharma giant’s $1.4 Merck has settled with insurance companies that contested the pharma giant’s $1.4 billion claim after it was victimized by a crippling cyberattack in 2017.

Insurance 199
article thumbnail

The importance in health insurance in retaining employees

World of DTC Marketing

Right now, annual raises are being neutralized by increasing healthcare insurance premiums. If pharma wants to retain people, they may have to develop a solution to lower healthcare insurance premiums. The average per-employee cost of employer-sponsored health insurance jumped 6.3 Employers in the U.S. percent and 5.2

Insurance 201
article thumbnail

2023 Likely To Be a Crucial Year for Pharma—and Insurers

MedCity News

2023 is shaping up to be a crucial year for everyone involved – and affected – by the pharmaceutical industry. It’s likely to be a year of experimentation for payers – and defensiveness for drug makers.

Insurance 296